AUTOLOGOUS CD4 T-CELL RESPONSES TO ECTOPIC CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN-EXPRESSING SINGLE-CELL ISLET CELLS - AN INVITRO INSIGHT INTO THE PATHOGENESIS OF LYMPHOCYTIC INSULITIS IN NONOBESE DIABETIC MICE

被引:23
作者
FORMBY, B
MILLER, N
机构
关键词
beta cells; diabetes;
D O I
10.1073/pnas.87.7.2438
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We investigated by flow cytometric analysis the expression of class II major histocompatibility complex (MHC) molecules by viable single-cell islet cells (SCICs) prepared from male and female 4- and 10-week-old nonobese diabetic (NOD) mouse islets. With anti-I-A(k) monoclonal antibody (specific for I-A(β)(k,f,r,s) and produced by clone 11-5-2), and fluorescein isothiocyanate-conjugated goat anti-mouse IgG as second-step antibody, we found that SCICs from both sexes aberrantly expressed class II MHC molecules, which was not altered after SCICs were cultured for 24 hr or 120 hr in the presence of 10 ng of recombinant murine interferon γ per ml. Double-indirect immunofluorescence of male SCICs indicated that the expression of class II MHC molecules was a property of beta cells. Control experiments documented that macrophages and mononuclear cells did not contaminate the SCIC preparations. Coculture experiments with responder splenic CD4 T cells isolated from diabetic NOD mice and stimulator male SCICs indicated a recognition event evidence by a 12-fold increase in proliferative response. Monoclonal antibodies to class II MHC and CD4 antigens blocked the proliferative response. Results from control autologous and allogeneic mixed lymphocyte reactions suggest that the responder CD4 T cells are autoreactive self-class II MHC restricted. We tentatively conclude that the ability of SCICs from both sexes of NOD mice to express class II MHC molecules as early as 4 weeks of age may represent a mechanism for targeting immune reactions to beta cells and initiate lymphocytic insulitis.
引用
收藏
页码:2438 / 2442
页数:5
相关论文
共 29 条
  • [1] BALLARDINI G, 1984, LANCET, V2, P1009
  • [2] SYNGENEIC TRANSFER OF AUTOIMMUNE DIABETES FROM DIABETIC NOD MICE TO HEALTHY NEONATES - REQUIREMENT FOR BOTH L3T4+ AND LYT-2+ T-CELLS
    BENDELAC, A
    CARNAUD, C
    BOITARD, C
    BACH, JF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) : 823 - 832
  • [3] PREVENTION OF DIABETES IN NONOBESE DIABETIC MICE BY ANTI-I-A MONOCLONAL-ANTIBODIES - TRANSFER OF PROTECTION BY SPLENIC T-CELLS
    BOITARD, C
    BENDELAC, A
    RICHARD, MF
    CARNAUD, C
    BACH, JF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (24) : 9719 - 9723
  • [4] ORGAN-SPECIFIC AUTOIMMUNITY - A 1986 OVERVIEW
    BOTTAZZO, GF
    TODD, I
    MIRAKIAN, R
    BELFIORE, A
    PUJOLBORRELL, R
    [J]. IMMUNOLOGICAL REVIEWS, 1986, 94 : 137 - 169
  • [5] INSITU CHARACTERIZATION OF AUTOIMMUNE PHENOMENA AND EXPRESSION OF HLA MOLECULES IN THE PANCREAS IN DIABETIC INSULITIS
    BOTTAZZO, GF
    DEAN, BM
    MCNALLY, JM
    MACKAY, EH
    SWIFT, PGF
    GAMBLE, DR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (06) : 353 - 360
  • [6] BOTTAZZO GF, 1983, LANCET, V2, P1115
  • [7] PRE-DIABETES IN THE SPONTANEOUSLY DIABETIC BB/E RAT - LYMPHOCYTE SUBPOPULATIONS IN THE PANCREATIC INFILTRATE AND EXPRESSION OF RAT MHC CLASS-II MOLECULES IN ENDOCRINE-CELLS
    DEAN, BM
    WALKER, R
    BONE, AJ
    BAIRD, JD
    COOKE, A
    [J]. DIABETOLOGIA, 1985, 28 (07) : 464 - 466
  • [8] FORMBY B, 1987, J PHARMACOL EXP THER, V241, P1106
  • [9] ABERRANT EXPRESSION OF HLA-DR ANTIGENS BY INSULIN-CONTAINING BETA-CELLS IN RECENT-ONSET TYPE-I DIABETES-MELLITUS
    FOULIS, AK
    FARQUHARSON, MA
    [J]. DIABETES, 1986, 35 (11) : 1215 - 1224
  • [10] INDUCTION OF INSULITIS BY ADOPTIVE TRANSFER WITH L3T4+LYT2- LYMPHOCYTES-T IN LYMPHOCYTE-T DEPLETED NOD MICE
    HANAFUSA, T
    SUGIHARA, S
    FUJINOKURIHARA, H
    MIYAGAWA, J
    MIYAZAKI, A
    YOSHIOKA, T
    YAMADA, K
    NAKAJIMA, H
    ASAKAWA, H
    KONO, N
    FUJIWARA, H
    HAMAOKA, T
    TARUI, S
    [J]. DIABETES, 1988, 37 (02) : 204 - 208